Rubicon Organics Inc. (OTCQX:ROMJF) Q4 2024 Earnings Conference Call April 2, 2025 10:00 AM ET
Company Participants
Margaret Brodie – CEO
Janis Risbin – CFO
Conference Call Participants
Neal Gilmer – Haywood Securities
Pablo Zuanic – Zuanic & Associates
Andrew Semple – Ventum Financial
Josh Felker – CB1 Capital
Operator
Good morning, everyone. Welcome to the conference call for Rubicon Organics Q4 Financial Results for the three and 12 months ended December 31, 2024. As a reminder, this conference call is being recorded on April 2, 2025.
At this time, all participants are in the listen-only mode. Following the presentation, we will conduct a question-and-answer session. Instructions will be provided at that time for research analysts to queue up for questions. Before we begin, I will refer you to Slide 2 of our presentation, which contains Rubicon’s caution regarding forward-looking statements and non-GAAP measures.
Today’s presenters will be Margaret Brodie, CEO, and Janis Risbin, CFO. I will now turn the call over to Margaret Brodie for the presentation.
Margaret Brodie
Good morning, everyone. Today I’ll provide an update on Rubicon Organics and our achievements in 2024 as Canada’s leading house of premium cannabis brands. I will also provide some color on our growth opportunities and where we are seeing — what we are seeing as a resurgence in Canadian cannabis. As well, our CFO Janis Risbin, will cover our financial highlights. 2024 was a record year for Rubicon Organics, achieving several milestones.
We delivered another record high net revenue for both the 3-month and 12-month periods ending December 31, 2024, up 21% and 42% respectively on 2023. We reported positive adjusted EBITDA of $4 million, excluding $900,000 in one-off ERP implementation costs, without which we would have been at our record high profitability of $5 million. We achieved three consecutive quarters of profit from operations. We swept the 2024 KIND Magazine Awards
Read the full article here
